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A B S T R A C T
The central nervous system regulates energy intake and expenditure through a complex network of
neurotransmitters and neuromodulators. It is of great interest to understand the relevance of these systems to
the physiological control of energy balance and to the disturbances of obesity. The present paper discusses
some of the methods to address this field used at the laboratory of Endocrine Physiology of Universidade
Federal de São Paulo. Initially, different experimental models of rat obesity are presented, namely the
hypothalamic induced monosodium glutamate model, the Zucker genetic model, and the dietary model. The
principles of brain microdialysis are also presented, the technique applied to obtain representative samples of
the extracellular fluid of brain sites involved in feeding control. The microdialysate levels of serotonin, an
important anorexigenic neurotransmitter, are determined by HPLC with electrochemical detection. The
immunoblot technique (Western blot) is used to determine hypothalamic levels of proteins relevant to the
anorexigenic effect of serotonin and to analyze the acute activation of the insulin signaling cascade in the
hypothalamus. The final section addresses the potential applications of proteomics in the study of the central
control of feeding.
Indexing terms: Brain microdialysis. Experimental Studies. Food intake. Hypothalamus. Obesity. Rats.
R E S U M O
O sistema nervoso central controla a ingestão e o gasto de energia por meio de um complexo circuito de
neurotransmissores e neuromoduladores. É de grande interesse entender a relevância fisiológica destes
sistemas e o papel que desempenham nos distúrbios da obesidade. No presente artigo, discutem-se alguns
dos métodos que têm sido utilizados no laboratório de Fisiologia Endócrina da Universidade Federal de São
Paulo, em estudos neste campo. Inicialmente, são apresentados alguns modelos de obesidade experimental
em ratos, como a obesidade hipotalâmica induzida por glutamato monossódico, o modelo genético Zucker e
também obesidades induzidas por dieta. Comenta-se, em seguida, sobre os princípios da microdiálise cerebral.
Esta  técnica é utilizada para obter amostras representativas do líquido extracelular de regiões cerebrais
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envolvidas no controle da ingestão alimentar. Os níveis de serotonina, um importante neurotransmissor
anorexígeno, são medidos no dialisato por cromatografia líquida de alta pressão com detecção eletroquímica.
Utiliza-se a técnica de immunoblot (Western blot) para determinar os níveis hipotalâmicos de proteínas
importantes na ação anorexigênica da serotonina e também para analisar a ativação aguda da cascata de
sinalização da insulina no hipotálamo. A seção final aborda o grande potencial da análise proteômica no estu-
do do controle central da ingestão.
Termos de indexação: Microdiálise cerebral. Estudos experimentais. Ingestão de alimentos. Hipotálamo.
Obesidade. Ratos.
I N T R O D U C T I O N
Body energy homeostasis depends on the
equilibrium of food intake and energy expenditure
and is influenced by multiple factors, of genetic,
metabolic, endocrine, neural, behavioral, and
environmental nature. All these factors may be
potentially involved in the pathogenesis of obesity,
although their relative participation may differ
among the different obesity syndromes.
A complex central nervous system (CNS)
circuit regulates food intake and energy
expenditure. Pivotal to this control are the
peripheral hormones, leptin, insulin and ghrelin,
which act as adiposity and satiety signals,
respectively, to the CNS. The neurons of the
arcuate nucleus (ARC) of the hypothalamus are
the main target of these circulating signals. The
ARC neurons express anabolic (orexigenic) and
catabolic (anorexigenic) neurotransmitters and
they innervate the medial nuclei (ventromedial -
VMH - and paraventricular - PVN) and the lateral
hypothalamus (LH). Additionally, food intake is
modulated by cortico-limbic brain structures, such
as the amygdala, prefrontal cortex, and nucleus
accumbens shell, which relay to the LH information
concerning the hedonic aspects of food. Through
these interactions, sensorial (taste, appearance,
smell, texture, etc.) and reward aspects exert a
powerful influence upon the homeostatic metabolic
control. Disruption of these complex physiological
interactions may lead to hyperphagia and/or
hypometabolism, the ultimate disturbances of
obesity1,2.
Rodents represent a very useful tool to
approach this field. The present paper discusses
some of the techniques that have been applied,
at the laboratory of Endocrine Physiology of
Universidade Federal de São Paulo (Unifesp), to
address the physiological and pathophysiological
relevance of hypothalamic mediators to feeding
homeostasis and obesity. Serotonin and insulin,
among others, and, more recently, glucose and
nitric oxide, are the mediators that have been
focused.
Serotonin is produced in the raphe nuclei
and released throughout the brain. Serotonergic
innervation of the hypothalamus exerts an
important anorexigenic action.   Brain microdialysis
is performed to estimate how hypothalamic
serotonergic activity responds to different
experimental manipulations, in both normal and
obese rats. The microdialysate levels of serotonin
(5-HT) and of its main metabolite, 5-hydroxi-
indolacetic acid (5-HIAA), are determined by high
pressure liquid chromatography (HPLC) coupled
with electrochemical detection. Additionally, the
immunoblot (Western blot) technique is used to
determine hypothalamic tissue levels of proteins
important to serotonin anorexigenic action, such
as the receptor subtypes 5-HT1B and 5-HT2C and
the serotonin transporter protein. Immunoblot has
also been used to analyze the acute activation of
the insulin signaling cascade in the hypothalamus.
The potential of proteomics in the study of the
central control of feeding is briefly commented in
the final section.
Producing the experimental “subjects”:
rodent obesity models
Modeling human obesity in rats and mice
offers a rich tool to explore the multifactorial nature
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of the disease. The various models reproduce
differently the diversity of obesity syndromes.
Hypothalamic obesity induced by
Monosodium Glutamate (MSG):
a non-hyperphagic model
MSG is a potent neuroexcitatory aminoacid.
When administered to a newborn animal, it
penetrates the SNC through the circunventricular
structures, due to their lack of a fully developed
blood brain barrier. Accumulating specially in the
ARC, MSG causes an excess of neuronal stimulation
and destroys 80-90% of the ARC neurons. The
treatment protocol involves the subcutaneous
injection of MSG in the dose of 4.0mg/g b.w.,
every second day, during the first 10 days of life.
After weaning, the animals are fed a balanced
diet until adulthood3-7.
The ARC is an important hypothalamic site
for energy homeostasis, with a high density of leptin
and insulin receptors being expressed in the
anorexigenic proopiomelanocortin (POMC) and
cocaine-and amphetamine-regulated transcript
(CART) neurons as well as in the orexigenic
neuropeptide Y (NPY) and agouti-related protein
(AgRP) neurons1,2. The destruction of these neurons
very early in life leads to multiple disturbances.
Rats treated neonatally with MSG develop into
obese and stunted adults, whose body weight is
not elevated but whose body composition is
abnormal, with increased fat and decreased lean
body mass. Importantly, the MSG-obese rats are
not hyperphagic and their excess body fat is caused
mainly by a low metabolism and depressed
thermogenesis rate3-7.
The Zucker genetic obesity
Although monogenic forms of obesity are
rare in humans, the study of single-gene mutated
animal models, such as the ob/ob, db/db, and
agouti mice, and the fa/fa rats represents a good
material to understand the syndrome.
The obesity of the Zucker rat strain is caused
by a spontaneous recessive mutation at the fa
locus (also called db locus), that is responsible for
the synthesis of the leptin receptor (LR) protein.
The mutation, a single A to C change in codon
880, leads to a glutamine to proline substitution
in residue 269, in the extracellular domain of the
LR protein. The fa/fa rats produce a truncated and
inactive LR and are thus resistant to the
hypothalamic anorexigenic action of leptin,
becoming hyperphagic and morbidly obese, despite
their hyperleptinemia. Obese fa/fa rats also present
hyperinsulinemia, insulin resistance, glucose
intolerance, and hyperlipidemia. The heterozygotes
for the mutation (Fa/fa) and the dominant
homozygotes (Fa/Fa) are lean5,8-10.
Obese Zucker rats are either sterile or
unable to mate and the maintenance of a Zucker
colony relies almost exclusively on the breeding
of lean heterozygotes, that are phenotypically
identical to the lean homozygotes. At
Universidade Federal de São Paulo (Unifesp), the
heterozygotes for breeding are currently being
identified at the main animal facility by a PCR
assay8. Briefly, when the animals are 1-mo-old,
their genomic DNA is purified from a tail fragment,
amplified, and the product (1.8 kb) digested with
the enzyme Msp1. The product of the wild type
gene has a single restriction site for the enzyme,
yielding 2 bands in the agarose gel, of 1000 bp
and 700 bp. In the product generated from the
mutated gene, there are two restriction sites and
the 1100 bp fragment is further cleaved, to yield
950 bp and 150 bp fragments8-10.
Dietary obesity
The easy access to hypercaloric and
palatable foods, rich in fats and/or carbohydrates,
is recognized as a major causal factor in the recent
obesity epidemic. Diet-induced obesity (DIO) in
rodents is considered to more closely reproduce
the “common” type of the human disease. Fat
and carbohydrates are palatable to the rat and
the exposure to these diets is able to affect the
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hedonic component of feeding and induce
overeating. However, similarly to what is seen in
humans, the susceptibility to DIO in rats is variable
and not all exposed individuals will become obese.
This is likely due to the interactions of the diets
with the genetic, metabolic, endocrine, neural,
and behavioral factors which determine
predisposition to obesity11,12. Understanding how
these diets interfere with the physiological systems
that control energy homeostasis has been the aim
of many studies and different types of high-fat
diets have been used. When selecting a diet
composition, it is important to consider that not
only the caloric density, but also the fatty acid
profile, is relevant to the determination of the
“obesogenic” capacity of dietary fat. Studies in
rodents indicate that mainly the saturated fatty
acids, but also the polyunsaturated fatty acids
(PUFA) of the n-6 and n-9 series are involved in
the genesis of hyper adiposity, dyslipidemia, and
insulin resistance11.
Hyperlipidic (HL) diets enriched with either
soy or fish oil, which are rich in n-6 and n-3 PUFAs,
respectively, have been used. The HL diets were
given to the animals for 8 weeks, starting at
weaning, and were prepared by adding, to the
control diet (rat balanced chow, 5% fat, 20%
protein, w/w, 2.8 Kcal/g), the necessary amount
of oil and also of casein to match the protein
content of the control chow13,14.
When the caloric density of the HL diet
was 4.9 Kcal/g (30% from fat), only the fish diet
induced excess weight gain13. On the other hand,
neither the soy nor the fish diet induced obesity
when yielding only 3.6kcal/g (40% from fat)14.
An important observation was that the plasma lipid
profile was not altered in the animals made obese
by the fish diet13. Also, in neither case was
hyperphagia observed. The daily intake of the HL
diets was actually decreased in a way that energy
intake was normal. This indicates that
hypometabolism rather than hyperphagia
contributed to the increased adiposity induced by
the fish diet13,14.
The development of a non-hyperphagic
obesity has also been observed using a palatable
HL diet (5.0kcal/g, 35% from fat) prepared by
adding chocolate, peanuts, and biscuits to the
control chow. However, unlike the fish diet, this
cafeteria diet induced dyslipidemia15.
Intrauterine undernutrition and obesity
It is accepted that the survival to
malnutrition during foetal and/or neonatal life
depends on growth and metabolic adaptations,
with the establishment of a “thrifty phenotype”.
Once developed, this economic metabolism may
become programmed and predispose to body
energy deposition in later life, especially if
combined with a good postnatal nutrition. In
humans, several adulthood pathologies have been
associated to poor early life nutrition, such as
cardiovascular diseases, insulin resistance with type
II diabetes, and obesity. Numerous undernutrition
protocols have been described to study the
consequences of intrauterine/perinatal undernutrition
in rats. They differ in terms of timing, severity,
and type of malnutrition, i.e., whether a protein
or a protein/energy restriction is applied.
Importantly, these differences do have impacts on
the final phenotype16.
The hypothalamic actions of insulin and
serotonin have been evaluated in adult rats food
restricted intrauterus. During the first 2 weeks of
pregnancy, the dams received only 50% of the
food amount consumed by the control dams.
During the last week of pregnancy and lactation,
they were pair-fed to the control dams, to avoid
compensatory hyperphagia. Their four-month-old
male and female progeny was studied. Gender
differences were detected, as only the restricted
females developed increased body fatness and
leptinemia. Although both genders had
impairment of insulin- and serotonin-induced
hypophagia, the females were more affected17,18.
Interestingly, impairment of the hypophagia
induced by insulin or serotonin, in the absence of
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obesity, has also been seen in adult male rats
whose mothers ate a normocaloric diet rich in
trans fatty acids19.
Estimating neurotransmitter release:
brain microdialysis
The understanding of diet interactions with
the brain systems involved in the regulation of
energy balance is of great interest. In our hands,
the combination of in vivo microdialysis, to sample
brain intracellular fluid, and HPLC with
electrochemical detection (EC), to measure
serotonin levels in the microdialysate samples, has
yielded numerous data on the participation of the
serotonergic system in the physiology and
pathophysiology of feeding control1,5,6,10,18,20-22.
The microdialysis technique (MD) is based
on the principle of dialysis, in which a semi
permeable membrane separates two compartments
while allowing a bidirectional flow of solutes
between them. The membrane is placed in the
brain tissue and perfused internally with an isotonic
physiological solution (called artificial cerebrospinal
fluid, CSF). After equilibration between the two
compartments, the composition of the collected
microdialysate reflects that of the brain extracellular
fluid. The microdialysis perfusion thus provides a
way to monitor in vivo neurochemistry of specific
brain regions and it has been widely used to
estimate neurotransmitter release23-27.
A less explored but also useful feature of
the technique is that it allows the supplying of a
substance or drug to the tissue, by adding it to the
perfusing solution, a feature known as reverse
dialysis or retrodialysis. Brain MD is also applicable
to humans. Monitoring of brain metabolism,
through determination of glucose, lactate, and
pyruvate levels during brain surgeries, has been
one of its applications23-27. These latter aspects will
not be considered in the following text.
The fact that brain MD is suitable for
continuous perfusion of a brain site in the awake,
freely-moving animal, has made the technique very
appropriate for behavioral studies. The MD set up
for an experiment in rats or mice must include a
perfusion pump, an MD probe, and an analytical
device to determine dialysate levels of the
substance of interest (Figure 1). Additionally,
although not mandatory, it is advisable that the
animal is connected to a counterbalanced arm
and swivel system, allowing probe perfusion
without any disturbances to movements and
normal behavior.
In the microdialysis probe, the membrane
is mounted in a way to allow its implantation in
the brain, its perfusion with isotonic CSF via the
inlet tube, and the collection of the dialysate via
the outlet tube. There are commercially available
MD probes but many laboratories custom made
their own devices, what can greatly lower the costs
of an MD experiment, even considering that some
probe parts are only available from foreign
suppliers. Unfortunately, the recovery capacity of
these home made probes is usually lower than
that of the industrialized ones. Figure 1 shows a
schematic drawing of the MD probe as
manufactured at Unifesp.
Figure 1. Schematic representation of the concentric microdialysis
probe (not drawn to scale). Probe assembly was
detailed elsewhere5,20.
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Probe recovery, i.e., the amount of the
substance of interest that actually enters the
microdialysate and becomes available for
detection, is a key characteristic of the MD
experiment. Absolute probe recovery is directly
proportional to perfusion rate and to membrane
length. However, because molecules in ECF must
equilibrate across the MD membrane, the relative
recovery decreases with increasing flow rates. It
is thus important that these aspects are examined,
as they can be modified to meet the needs of a
particular experiment. In general, rat brain MD
experiments apply flow rates in the range of 1.0
to 3.0µl/min. and membrane lengths between of
1.0 to 4.0mm, depending on the brain area.
Typically, each dialysate sample is collected for
10 to 20min23-27.
Potentially, every substance recovered to
the microdialysate sample can be quantitated,
provided that a sufficiently sensitive analytical
method is used. This is usually an important issue,
due to the small volumes of dialysate obtained
and the low amount of analytes in the sample.
However, as the passage through the MD
membrane excludes large molecules, such as large
proteins, MD samples have the advantage of
being highly purified, making it unnecessary to
prepare the sample before analysis.
Numerous brain MD studies have focused
on monoaminergic and cholinergic transmission,
and HPLC coupled with electrochemical detection
(EC) has been the method of choice to determine
neurotransmitter levels in MD samples. This
method has been used to determine the levels of
serotonin and its main metabolite (5-HIAA) in MD
samples collected from the hypothalamus.
Because it is present in very low amounts in the
hypothalamic microdialysates (in the order of
fentomols), serotonin requires a high sensitivity
method to be detected and HPLC-EC conditions
able to maximize the capacity to measure this
amine have been adopted5,6,10,18,20-22.
Using this approach, it has been shown that
serotonin release in the lateral hypothalamus was
stimulated by the ingestion of food, suggesting a
physiological mechanism elicited to achieve satiety.
This modulatory response was preserved in
MSG-obese rats. On the other hand, obese Zucker
rats had an exacerbated serotonergic response to
food, probably due to resistance to the released
neurotransmitter. A similar profile was found in
female adult rats undernourished in utero, which
were obese, had impairment of serotonin
hypophagia and enhanced release of serotonin in
response to a meal1,5,6,18.
The putative interactions of serotonin with
leptin, NPY, and interleukin-1b have also been
evaluated. A single intracerebroventricular leptin
injection failed to affect serotonin release but
potentiated the food-induced serotonin release
while inhibiting food ingestion. NPY, a potent
orexigenic factor, had a dual effect on LH
serotonin. When a low dose was given i.c.v.,
serotonin release was stimulated as the animal
ingested food. However, higher NPY doses induced
higher intakes but blocked serotonin release. These
findings indicated that the serotonergic system is
involved in the effects elicited by leptin and NPY
in normal rats. Additionally, in obese Zucker rats
it has been found that the hypophagia induced by
interleukin-1b depends on the serotonin released
in the medial hypothalamus and that the nitric
oxide system counteracts this effect1,10,21,22.
As already pointed out, the brain MD
sample is a rich source of information, since it
contains a multitude of substances recovered from
the tissue. Our studies are currently being expanded
by the implementation of the methodologies for
detection of glucose (by the glucose oxidase
method) and nitric oxide (by chemiluminescense)
in the microdialysates.
Detecting brain proteins: immunoblot
and proteomics
Analytical methods based on protein
detection are broadly used. Immunoblot (also
called Western blot) is a semi-quantitative method
based on the binding of the protein of interest to
a specific antibody. The first step is to prepare a
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tissue extract by homogenizing a fragment in the
appropriate buffer containing protease inhibitors.
After centrifugation, the supernatant is loaded on
a polyacrylamide gel to which an electrical
potential is applied, leading to the separation of
the proteins in individual bands, as they migrate
on the gel on the basis of their size (molecular
weight). This procedure is known as SDS-PAGE
(sodium dodecyl sulfate polyacrylamide gel
electrophoresis).
The so resolved proteins are transferred
from the gel medium to a nitrocellulose membrane
and this sheet is incubated with the specific
antibody, directed against the protein of interest.
This primary antibody binds to the protein (band)
and the reaction can be detected by various ways.
One sensitive detection method is the application
of a secondary antibody conjugated with the
enzyme horseradish peroxidase (HRP). The
secondary antibody is an IgG directed against the
animal species in which the primary antibody was
raised. It binds to the primary antibody and is
developed by chemiluminescence, after the
addition of a substrate for the HRP, usually luminol,
in the presence of hydrogen peroxide. By exposing
the blot to an X-ray film, the bands are visualized
and further quantitated by densitometry, the results
being usually expressed as arbitrary densitometric
units. As the method is semi quantitative, it is
important that each gel includes samples from all
the groups being compared in an experimental
design28,29.
Immunoblot applications in the field of brain
control of food intake are wide. This method has
been used to determine hypothalamic levels of
the serotonin receptor proteins, of the 5-HT1B and
5-HT2C subtypes, and also of the serotonin
transporter protein. It was possible to demonstrate
that these protein levels were affected in the
hypothalamus of rats fed hyperlipidic diets and
also in adult rats undernourished in uterus14,18.
Proteins involved in the transmission of the
insulin signal in the hypothalamus may also be
quantitated by immunoblot. Additionally, it is
possible to evaluate the ability of insulin to
stimulate its signaling pathway by determining the
level of phosphorylation of these signaling proteins.
The hypothalamic, anorexigenic action of insulin,
has been shown to depend on the activation of
the phosphatidylinositol 3-kinase (PI3-K) pathway.
Insulin binding to its receptor (IR) induces its
autophosphorylation and activates its tyrosine
kinase activity towards receptor substrates, such
as IR substrate-1 (IRS-1) and IR substrate-2 (IRS-2).
Phosphorylated IRSs activate PI3-K, leading to the
phosphorylation of protein kinase B (or Akt, a
serine/threonine kinase)2. By using anti-
phosphotyrosine as the primary antibody, it is
possible to estimate the activation of the initial
steps of insulin signaling, i.e., IR and IRSs tyrosine
phosphorylation. With this approach, impairment
of insulin signaling has been demonstrated in the
hypothalamus of obese Zucker rats and of rats
undernourished or fed with trans fatty acids intra
uterus9,17,19.
Finally, the perspectives of a novel and
promising method in nutrition research, namely
the proteomic analysis, will be commented. The
term proteomics designates the analysis of the
complement of proteins (or the proteome) of a
tissue, organ or organism. It has advantages over
the analysis of gene expression, as it allows the
evaluation of the proteins actually produced, with
their post transcriptional and post translational
modifications. There are various described
proteomics methods. In the 2D-PAGE MALDI-TOF
MS, the analysis starts with a two-dimensional
separation of the proteins. In the first dimension
(isoelectric focusing), proteins are separated
according to their net charge (isoelectric point).
The second dimension is a SDS-PAGE, with
separation by size.
The proteins appear as spots after the
staining of the gel. An image analysis software
allows the identification of the spots with different
densities between treatment groups, indicating the
proteins whose expression was modified by the
treatments applied. As the analysis is comparative,
every set of gels must contain one sample from
each treatment group included in the experimental
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design. The spots of interest are selected and
enzymatically digested, the peptide fragments
extracted and analyzed by mass spectrometry
(MS). The preparation of the peptides for MS
involves their evaporation and ionization, by the
method of matrix-assisted laser desorption
ionization (MALDI). The separation of the ionized
peptides occurs in high vacuum, according to their
mass-to-charge ratios, which determines their
time-of-flight (TOF) to reach the detector. The
fragments are compared to a protein bank and
the results expressed as a probability score of
identity of the protein30,31.
At Unifesp, with the supervision of the
group of Dr. Dulce Elena Casarini, the methodology
for proteomic analysis of hypothalamic extracts,
from rats fed chronically with modified diets, has
just been established. It is anticipated that the
results will lead to important insights into the
complex interactions of diet components and
hypothalamic proteins and help the understanding
of the complex pathophysiology of obesity.
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